Supplementary Tables S1-S36 from Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy
Zachary Z. Reinstein(Northwestern University), Jaehyuk Choi(Northwestern University), Robbert J.C. Slebos(University of Iowa), Carlos Moran Segura(Moffitt Cancer Center), Jane L. Messina(Moffitt Cancer Center), Christine H. Chung(Moffitt Cancer Center), Karol Prieto(Pontificia Universidad Javeriana), Jonathan S. Zager(Moffitt Cancer Center), Spencer Ng(Northwestern University), Rui Yin(Advanced Bioscience Laboratories (United States)), Janis V. de la Iglesia, Amod A. Sarnaik(Moffitt Cancer Center), Andrew S. Brohl(Moffitt Cancer Center), Sunandana Chandra(Northwestern University), Kenneth Y. Tsai(Moffitt Cancer Center), Sungjune Kim(Moffitt Cancer Center), Jeffrey B. Cheng(Cleveland Clinic), Charles Vaske(Dovetail Genomics (United States)), Brian G. Pierce(University of Maryland, Baltimore), Raymond J. Cho(University of California, San Francisco), Xinlei Mi(BC Children's Hospital), Ellie Ivanova(New York University), Matt D. Nichols(Moffitt Cancer Center), Victoria A. Chu(Northwestern University), Nikhil I. Khushalani(Roswell Park Comprehensive Cancer Center), Vernon K. Sondak(Advanced Dermatology), Jeffrey A. Sosman(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Oscar E. Ospina(Moffitt Cancer Center), Sergei B. Koralov(NYU Langone’s Laura and Isaac Perlmutter Cancer Center), Brittney Sell(Florida State University), Jonathan V. Nguyen(University of California, San Francisco), A. Usman(Northwestern University), Yue Zhang(Wuhan University), Álvaro de Mingo Pulido(Institut d'Investigacions Biomèdiques de Barcelona), Xuefeng Wang(Xuzhou Medical College), Brooke L. Fridley(Children's Mercy Hospital)
Cited by 0
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k